Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott C Woller

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 28, 2021
Natural Language Processing Performance for the Identification of Venous Thromboembolism in an Integrated Healthcare SystemBela Woller, Austin Daw, Valerie Aston, et al.
Thrombosis Research|May 9, 2025
Prescribing preferences for reduced-dose direct oral anticoagulation for extended-phase venous thromboembolism treatmentDanielle Groat, Karlyn A Martin, Rachel P Rosovsky, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 25, 2011
Computer surveillance of patients at high risk for and with venous thromboembolismR Scott Evans, James F Lloyd, Valerie T Aston, et al.
The American Journal of Medicine|October 4, 2011
Derivation and validation of a simple model to identify venous thromboembolism risk in medical patientsScott C Woller, Scott M Stevens, Jason P Jones, et al.
Research and Practice in Thrombosis and Haemostasis|December 1, 2025
Risk of venous thromboembolism associated with short-term exposure to fine particulate matter (PM<sub>2.5</sub>) and ozone air pollutionScott C Woller, Scott M Stevens, Joseph R Bledsoe, et al.
Journal of Clinical Medicine|January 11, 2024
Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism TreatmentDanielle Groat, Karlyn A Martin, Rachel P Rosovsky, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Predicting postdischarge hospital-associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkersLindsey Snyder, Scott M Stevens, Masarret Fazili, et al.
Research and Practice in Thrombosis and Haemostasis|June 15, 2022
Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatmentDanielle Groat, Karlyn A Martin, Rachel P Rosovsky, et al.
Cardiology Research and Practice|January 30, 2015
Antithrombotic therapy in patients with acute coronary syndrome in the intermountain heart collaborative studyStacey Knight, Winslow Klaskala, Scott C Woller, et al.
Research and Practice in Thrombosis and Haemostasis|October 16, 2023
Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasoundAnna L Parks, Masarret Fazili, Valerie Aston, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 28, 2021
Natural Language Processing Performance for the Identification of Venous Thromboembolism in an Integrated Healthcare SystemBela Woller, Austin Daw, Valerie Aston, et al.
Thrombosis Research|May 9, 2025
Prescribing preferences for reduced-dose direct oral anticoagulation for extended-phase venous thromboembolism treatmentDanielle Groat, Karlyn A Martin, Rachel P Rosovsky, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 25, 2011
Computer surveillance of patients at high risk for and with venous thromboembolismR Scott Evans, James F Lloyd, Valerie T Aston, et al.
The American Journal of Medicine|October 4, 2011
Derivation and validation of a simple model to identify venous thromboembolism risk in medical patientsScott C Woller, Scott M Stevens, Jason P Jones, et al.
Research and Practice in Thrombosis and Haemostasis|December 1, 2025
Risk of venous thromboembolism associated with short-term exposure to fine particulate matter (PM<sub>2.5</sub>) and ozone air pollutionScott C Woller, Scott M Stevens, Joseph R Bledsoe, et al.
Journal of Clinical Medicine|January 11, 2024
Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism TreatmentDanielle Groat, Karlyn A Martin, Rachel P Rosovsky, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Predicting postdischarge hospital-associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkersLindsey Snyder, Scott M Stevens, Masarret Fazili, et al.
Research and Practice in Thrombosis and Haemostasis|June 15, 2022
Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatmentDanielle Groat, Karlyn A Martin, Rachel P Rosovsky, et al.
Cardiology Research and Practice|January 30, 2015
Antithrombotic therapy in patients with acute coronary syndrome in the intermountain heart collaborative studyStacey Knight, Winslow Klaskala, Scott C Woller, et al.
Research and Practice in Thrombosis and Haemostasis|October 16, 2023
Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasoundAnna L Parks, Masarret Fazili, Valerie Aston, et al.
Pageof 9